INTRODUCTION
============

Arsenic (As) is a metalloid found in water, soil, and air from natural and anthropogenic sources ([@b10-ajas-25-9-1262-8]). Arsenic occurs in both organic and inorganic forms in nature, but the inorganic form is more toxic and represents a potential threat to the environment, human health, and animal health. Various livestock animals are also the likely victims of such catastrophes arising from As pollution due to contamination of drinking water. Administration of As could affect animal performances and serum clinical parameters. Liver and kidneys are considered as the primary targets for its toxico-pathological manifestations and there are a few reports of biochemical alterations indicative of hepatic and renal system involvement in As toxicity in animals ([@b3-ajas-25-9-1262-8]; [@b28-ajas-25-9-1262-8]; [@b18-ajas-25-9-1262-8]). However, little data have been reported in lactating dairy animals. For cattle, sheep and swine maximum tolerable dietary As recommended is 50 g/kg (inorganic) and 100 mg/kg (organic). The purpose of this study was to evaluate the cumulative effect of recommended inorganic As in a long term exposure in lactating goats. In rat model, beneficial role of antioxidants have been reported earlier against As toxicity ([@b24-ajas-25-9-1262-8]; [@b19-ajas-25-9-1262-8]). Beneficial role of feeding ascorbic acid as an antioxidant has been reported in rabbit ([@b23-ajas-25-9-1262-8]), rat ([@b19-ajas-25-9-1262-8]) and in rodents ([@b25-ajas-25-9-1262-8]). Likely, vitamin E is a dietary essential which act as first line of defence in ruminants against pro-oxidant. As the vitamin E requirement of all classes goat is 100 IU/kg ([@b17-ajas-25-9-1262-8]), therefore 100 and 150 IU/kg doses are decided to evaluate the antioxidant effect. Taking into consideration of the above facts, the present investigation was undertaken to assess the protective effect of vitamin E at two levels against As induced changes in hematological and plasma biochemical variables indicative of hepatic and renal functions in lactating goats.

MATERIALS AND METHODS
=====================

Experimental design and treatments
----------------------------------

A total of 24 crossbred lactating goats (2nd to 3rd stage of lactation) were selected from the Cattle Yard of National Dairy Research Institute, Karnal, India and distributed randomly into 4 groups of 6 each. The distribution of the animals was done on the basis of average milk yield (1.61±0.04 kg/d) and body weight (36.10±0.11 kg). The experimental feeding period was of 12 months. The details of the treatments are as follows:

1.  Group I (C): Control animals

2.  Group II (T~1~): Arsenic as sodium arsenite, 50 mg/kg dry matter (DM)

3.  Group III (T~2~): Arsenic as in group II plus vitamin E, 100 IU/kg DM

4.  Group III (T~3~): Arsenic as in group II plus vitamin E, 150 IU/kg DM

Diets and feeding
-----------------

The goats were housed in well ventilated pens having facilities for individual feeding. Deworming schedule was followed at the beginning of the experiment and thereafter, at six month interval. The experiment was performed with approval from Institute (NDRI, India) Animal Ethics Committee (IAEC No. 28/09-21/11/2009). Before the trial, animals were adapted to the new environment and fed As and vitamin E capsule for 7 days. The animals were fed as per [@b20-ajas-25-9-1262-8] feeding standard to meet their nutrient requirements. The concentrate mixture was offered in the morning in the plastic tubs whereas, the chaffed green fodder was offered at 11:00 AM. As it was a long term study, two types of fodder either berseem or maize depending upon the season/availability was provided. Concentrate mixture (maize 33%, groundnut cake (oiled) 21%, mustard oil cake (oiled) 12%, wheat bran 20%, deoiled rice bran 11%, mineral mixture 2% and common salt 1%) having CP 19.81% and TDN 70% was procured from Godrej Agrovet Pvt Ltd. Composition of roughage and concentrate mixture was estimated by drawing weekly samples and every effort was made to maintain the supply of the given fodder of similar composition. Content of As in concentrate mixture, berseem and maize were 1.116, 0.10 and 0.09 mg/kg and content of vitamin E were 10.72, 24.86 and 5.99 mg/kg respectively. 50 mg elemental As/kg dietary DM as sodium arsenite (s-d-Fine-Chem Limited, India, purity 98.5%) and 100 and 150 IU vitamin E/kg dietary DM as dl-α-tocopheryl acetate (Lutavit, BASF, Germany, minimum assay 50%) was weighed, packed in gelatine capsules. Arsenic containing capsules were administered orally to each goat of T~1~, T~2~ and T~3~ groups whereas vitamin E capsules of 100 IU and 150 IU doses were given to each goat of T~2~ and T~3~ groups, respectively. The concentration of As was also determined in the water that the animals drank and was found to be 0.003 mg/L. Proximate analysis (DM, CP, EE, CF, NFE and ash) of concentrate mixture, green fodder (berseem and maize) was performed according to methods described in AOAC (2005).

Collection and processing of blood samples
------------------------------------------

Blood samples were collected aseptically from jugular vein of each animal using heparinized vacutainer tube (Becton Dickinson India Pvt. Ltd., New Delhi, India). Immediately after collection, tubes were placed in freeze (4°C) and analyzed subsequently. Plasma was harvested subsequently by centrifuging the whole blood samples at 840 g for 15 min in a portable centrifuge machine (HERMLE Labortechnik GmbH, Germany). The heparinized plasma samples were stored at −20°C in storage vials and analyzed subsequently.

Hematological parameters
------------------------

The haemoglobin (Hb) content of blood was estimated by Drabkin cyanomethemoglobin method ([@b6-ajas-25-9-1262-8]). Blood leukocytes (TLC) and lymphocyte % were done using Neubauer chamber.

Biochemical estimation
----------------------

### Plasma biochemical parameters

Activity of plasma AST and ALT was estimated following the method of Reitman and Frankel ([@b27-ajas-25-9-1262-8]) using commercial kit (Span Diagnostics Ltd, Surat, India) and the values were expressed as U/L of plasma. Plasma Total protein was measured using modified Biuret method ([@b13-ajas-25-9-1262-8]) and values were expressed in gm/dl. Plasma creatinine was measured spectrophotometrically using alkaline picrate method ([@b5-ajas-25-9-1262-8]).

Statistical analysis
--------------------

The data were analyzed using two way repeated measures ANOVA (Sigma Plot software, version 11.0; SPSS Inc., Chicago IL, USA) with two factors i.e., different treatment groups and periods. All results were compared to control animals, as well as to the As exposed animals, in order to elucidate the possible protective effect of vitamin E supply on As toxicity. Tukey's all pair wise multiple comparison tests have been used to compare means between the different treatment groups. The results were represented as mean±SE in the treatment and period interaction table mentioning the significance level. The specific p values were mentioned in the text for where there was significant difference found.

RESULTS AND DISCUSSION
======================

After an initial increase (p = 0.034) in Hb concentration at 2 months in T~2~, thereafter there was gradual decline in Hb content, thereby suggesting that As administration had an adverse effect as the period of exposure was increased thus confirming its cumulative potential which might have been reflected in depression of Hb ([Table 1](#t1-ajas-25-9-1262-8){ref-type="table"}). Treatment×period interaction (p\<0.001) was observed during the study. Both T~2~ and T~3~ groups started to show its positive effect in increasing Hb compared to T1 from 8th (p\<0.001) and 6th (p = 0.015) months onwards respectively and but statistically there was no difference (p\>0.05) between these groups thus it can be concluded that vitamin E supplementation can alleviate adverse effect on Hb due to As supplementation. But the final value in T~2~ and T~3~ was different (p\<0.001) from control, so dose of vitamin E was not sufficient enough to completely mitigate the adverse effect caused by As. It is also evident from the overall mean values of dietary treatment.

In all As supplemented groups showed a periodically declining trend of TLC compared to control thus indicating its adverse effect ([Table 2](#t2-ajas-25-9-1262-8){ref-type="table"}). Group T~1~ showed its adverse effect (p = 0.005) from 7 months whereas T~2~ and T~3~ were effective (p\<0.001) in mitigation of adverse effect from 10 months onwards. As the experimental feeding was continued further, the declining trend maintained and the group T~1~ showed maximum reduction at the end of 12 months feeding. From the overall mean values of treatments, it was found that vitamin E supplementation at its higher doses significantly mitigate As induced reduction of blood TLC. Treatment×period interaction (p\<0.001) was found during the experimental period.

The present study revealed that As exposed goats suffered from hematological abnormality and these findings were similar to those reported in cattle selected from As contaminated zone ([@b21-ajas-25-9-1262-8]; [@b25-ajas-25-9-1262-8]). Similarly, [@b3-ajas-25-9-1262-8] and [@b21-ajas-25-9-1262-8] recorded decreased level of Hb and marked leucopenia in experimentally produced As toxicity in goats. Reduction of Hb and TLC might be due to interference in metabolism, suppression of the granulopoietic activity of bone marrow by residual toxicants ([@b11-ajas-25-9-1262-8]; [@b26-ajas-25-9-1262-8]), increased rate of destruction or reduction in rate of formation of erythrocytes and altered cellular composition of blood leading to anemia, anisocytosis, eosinophilia and leucopenia and also due to impaired absorption of folic acid ([@b8-ajas-25-9-1262-8]) and disruption of liver biosynthesis of heme ([@b32-ajas-25-9-1262-8]). Regarding vitamin E effect, decreasing trend of Hb and TLC was observed in As with vitamin E supplemented animals compared to control but that was not statistically significant. The results were in agreement with findings by [@b22-ajas-25-9-1262-8] and [@b30-ajas-25-9-1262-8] in growing kids.

Due to experimental feeding AST values were increased at the end of experiment in control, T~1~, T~2~ and T~3~ groups, respectively. Results showed that there was periodical increase in plasma AST activities in all the treatment groups as compared to control which remained almost similar ([Table 3](#t3-ajas-25-9-1262-8){ref-type="table"}). Treatment×period interaction (p\<0.001) was observed during the study. In As supplemented group, increase (p = 0.005) in AST activities was found from 4 months onwards. This clearly indicated initiation of adverse effect of As supplementation. Both the vitamin E supplemented groups showed protective effect (p\<0.01) of As from 9 months onwards however between the two doses there was no (p\>0.05) difference. Though at the end of experiment AST values in T~2~ and T~3~ were lower than those in group T1 but still differed (p\<0.001) as compared to control. From the overall mean values it was found that vitamin E supplementation at its higher doses ameliorate As induced increase in AST activity.

In T1, T~2~ and T~3~ groups, with the increase of duration of exposure there was gradual increase of ALT activities ([Table 4](#t4-ajas-25-9-1262-8){ref-type="table"}). Treatment×period interaction (p = 0.001) was also encountered during the experimental period. T~1~ groups started showing its adverse effect (p = 0.024) after one month of As supplementation. Up to 8 months activity in T~3~ was comparable to control. After that in both T~2~ and T~3~ groups, activities were increased (p\<0.001) in comparison to control group up to the end of experiment but less than T~1~. From the overall mean values it was observed that vitamin E at both the doses was not able to mitigate significantly As induced increase in ALT activities.

In the present investigation, there was an increased activity of AST and ALT in As supplemented animals. As a toxic metal, arsenic undergoes biotransformation in the liver and cause hepatic as well as systemic oxidative stress ([@b19-ajas-25-9-1262-8]). However, the liver hepatocytes are affected by the As as it binds with the thiol group of enzymes and protein present in the cells thus it disfuctionate the hepatocytes plasma membrane leading to increased AST and ALT activities ([@b32-ajas-25-9-1262-8]). Similar observations have been reported by [@b21-ajas-25-9-1262-8], [@b30-ajas-25-9-1262-8] and [@b22-ajas-25-9-1262-8] in As supplemented goat. [@b25-ajas-25-9-1262-8] also reported significant elevation (p\<0.05) in plasma ALT (7.452±0.10) and AST (33.21±0.12) activities in cattle of As contaminated area (Ghentugachi village, Nadia district) compared to uncontaminated zone (6.51±0.10 and 28.23± 0.21) that might be resulted from As mediated hepatic injury. However, [@b16-ajas-25-9-1262-8] reported non significant effect of dietary supplementation of As at 50 ppm on ALT activity in crossbred calves during 90 days of study. The more pronounced adverse effect of As on serum transaminases activities is of significance in view of the involvement of these variables in heme synthesis and hepatic function. In the present experiment, supplementation of vitamin E was able to reduce activity of these enzymes that might be due to its ability to protect free radicals responsible for oxidative stress and thereby inhibiting the production of ROS. [@b1-ajas-25-9-1262-8] also reported the protective effect of vitamin E in reducing AST and ALT activity to a normal level when injection of vitamin E at 20 mg and Se at 0.22 mg/kg body weight was given in Saibi lambs. In conflict with the result, [@b30-ajas-25-9-1262-8] reported non significant (p\>0.05) effect of vitamin E supplementation on these enzyme activities during three months of experimental feeding of As. That might be due to lower dose (50 IU/kg DM) of vitamin E.

Overall, there was no effect of dietary treatments on plasma total protein. At the end of the experiment T~1~ group showed lower (p = 0.048) plasma protein compared to control group. Periodically there was decline trend observed ([Figure 1](#f1-ajas-25-9-1262-8){ref-type="fig"}). There was no treatment×period interaction. Vitamin E in both the doses produced significant effect in improving total protein level at the end of experiment. There was increased trend (p\<0.05) of plasma creatinine level in all As treated groups. Vitamin E in both the doses produced significant effect (p\<0.05) in improving creatinine level at the end of experiment. There was no treatment×period interaction ([Figure 2](#f2-ajas-25-9-1262-8){ref-type="fig"}).

Serum biochemistry profiles are sensitive serological indicator of kidney toxicity. Decreased serum total protein in the trial was similar to the results obtained by [@b18-ajas-25-9-1262-8] in rats but in contrast to the report of [@b29-ajas-25-9-1262-8] in rats, [@b4-ajas-25-9-1262-8] in goats and [@b31-ajas-25-9-1262-8] in pigs. Hypoproteinaemia in arsenic-induced animals is likely to be due to marked destruction and disintegration of parenchymatous tissues. It is also possible that severe nephrotoxic lesions caused drainage of protein through the urine, resulting to hypoproteinaemia. The elevation of serum protein after vitamin E supplementation was probably due to decreased hepatic insulin resistance allowing insulin to stimulate the incorporation of amino acids into protein ([@b15-ajas-25-9-1262-8]). Increased plasma creatinine was similar to [@b18-ajas-25-9-1262-8] but in contrast with [@b31-ajas-25-9-1262-8]. Increased creatinine level indicates initiation of renal infliction due to persistent exposure of As. Blood creatinine is a common test used to evaluate kidney function. So, kidney dysfunction (alteration in glomerular filtration) results in decreased creatinine and blood urea nitrogen clearance and therefore increases their blood levels ([@b12-ajas-25-9-1262-8]). Vitamin E supplementation reduced the As induced increase in creatinine level which may be due to the antioxidant effect of the vitamins.

Critical perusal of the results suggested that As exposure resulted in varying degree of changes in hemato-biochemical parameters in lactating goats. Concomitant treatment with vitamins such as α-tocopherol reduced As burden as compared to untreated group but the reduction was not sufficient enough to be comparable to that of unexposed controls, thus revealed specific protection of α-tocopherol from biochemical damage and thus may be helpful to combat As-associated sufferings in animal.

![Effect of vitamin E supplementation on plasma total protein (g/dl) level in As fed goats. Bar indicate means±SE. Means followed by the same letter are not significantly different from each other (p\<0.05).](ajas-25-9-1262-8f1){#f1-ajas-25-9-1262-8}

![Effect of vitamin E supplementation on plasma creatinine level in As fed goats. Bar indicate means±SE. Means followed by the same letter are not significantly different from each other (p\<0.05).](ajas-25-9-1262-8f2){#f2-ajas-25-9-1262-8}

###### 

Effect of vitamin E supplementation on blood Hb (gm %) in As fed goats

  Period (Months)   Treatments      Mean                                              
  ----------------- --------------- ---------------- --------------- ---------------- ------------
  0                 9.27±0.12       8.90±0.23        9.06±0.14       9.52±0.18        9.19±0.13
  1                 9.87±0.36       9.93±0.38        10.49±0.45      10.05±0.27       10.09±0.14
  2                 9.59^a^±0.14    10.17^ab^±0.29   10.45^b^±0.30   10.31^ab^±0.25   10.13±0.19
  3                 9.85±0.35       9.29±0.11        9.58±0.18       9.63±0.23        9.58±0.12
  4                 10.13^b^±0.05   9.11^a^±0.16     9.40^ab^±0.15   9.71^ab^±0.19    9.59±0.22
  5                 9.80^b^±0.23    8.26^a^±0.13     9.01^ab^±0.23   9.39^b^±0.16     9.12±0.33
  6                 10.31^c^±0.26   8.00^a^±0.12     8.81^ab^±0.26   8.95^b^±0.22     9.01±0.48
  7                 10.15^c^±0.33   7.84^a^±0.11     8.55^ab^±0.16   8.75^b^±0.22     8.82±0.48
  8                 9.94^c^±0.12    7.41^a^±0.12     8.36^b^±0.27    8.61^b^±0.25     8.58±0.52
  9                 9.78^c^±0.19    7.12^a^±0.20     8.21^b^±0.21    8.43^b^±0.26     8.38±0.55
  10                9.45^c^±0.16    6.74^a^±0.19     8.02^b^±0.17    8.11^b^±0.26     8.08±0.55
  11                9.46^c^±0.21    6.45^a^±0.18     7.80^b^±0.21    7.89^b^±0.25     7.90±0.62
  12                9.42^c^±0.22    6.40^a^±0.12     7.74^b^±0.20    7.78^b^±0.22     7.83±0.62
  Mean              9.77^c^±0.09    8.12^a^±0.36     8.88^b^±0.25    9.01^b^±0.23     

Mean within the row bearing different superscript (a, b, c) are significantly different (p\<0.05).

###### 

Effect of vitamin E supplementation on blood total leukocyte count (×10^3^/mm^3^) in As fed goats

  Period (Months)   Treatments      Mean                                           
  ----------------- --------------- -------------- --------------- --------------- ------------
  0                 11.18±0.43      11.20±0.70     12.03±0.13      11.55±0.69      11.49±0.20
  1                 11.12±0.46      10.50±0.52     11.20±0.31      11.27±0.27      11.02±0.18
  2                 10.67±0.73      10.37±0.58     11.02±0.33      11.14±0.15      10.80±0.18
  3                 10.47±0.38      10.47±65       10.83±0.36      10.98±0.26      10.69±0.13
  4                 10.25±0.48      10.05±0.33     10.45±0.40      10.83±0.27      10.40±0.17
  5                 10.22±0.51      9.87±0.28      10.27±0.33      10.70±0.34      10.26±0.17
  6                 10.28±0.30      9.14±0.34      9.54±0.29       10.27±0.64      9.80±0.28
  7                 10.42^b^±0.33   8.60^a^±0.29   9.24^ab^±0.34   9.66^ab^±0.45   9.48±0.38
  8                 10.30^b^±0.37   8.20^a^±0.30   9.08^ab^±0.43   9.54^ab^±0.26   9.28±0.44
  9                 10.44^c^±0.28   7.39^a^±0.31   8.20^ab^±0.19   8.92^b^±.29     8.73±0.65
  10                10.33^c^±0.33   5.88^a^±0.32   7.69^b^±0.28    8.23^b^±0.30    8.03±0.92
  11                10.23^c^±0.34   5.61^a^±0.28   7.47^b^±0.33    8.16^b^±0.36    7.87±0.95
  12                10.15^c^±0.38   4.72^a^±0.26   7.14^b^±0.28    7.86^b^±0.35    7.47±1.12
  Mean              10.46^b^±0.09   8.61^a^±0.59   9.55^c^±0.44    9.93^bc^±0.36   

Mean within the row bearing different superscript (a, b, c) are significantly different (p\<0.05).

###### 

Effect of vitamin E supplementation on AST activity (U/L) in As fed goats

  Period (Months)   Treatments       Mean                                                 
  ----------------- ---------------- ---------------- ----------------- ----------------- --------------
  0                 94.6±4.12        87.31±5.06       90.47±5.23        92.53±5.00        91.23±1.56
  1                 98.19±5.12       95.03±3.41       92.02±5.45        93.33±4.85        94.64±1.33
  2                 93.80±5.80       102.05±5.85      98.78±4.92        96.94±4.48        97.89±1.73
  3                 106.53±5.87      125.50±6.17      117.16±5.81       110.94±4.50       115.03±4.11
  4                 102.25^a^±6.31   129.07^b^±5.42   109.88^ab^±5.45   111.30^ab^±4.00   113.13±5.68
  5                 105.42^a^±5.46   137.89^b^±4.34   129.60^b^±4.95    119.54^ab^±4.80   123.11±6.99
  6                 125.21^a^±5.28   145.92^b^±4.69   137.73^ab^±4.63   128.08^ab^±4.84   134.23±4.73
  7                 89.16^a^±4.28    133.95^b^±5.19   123.89^b^±5.08    120.49^b^±4.12    116.87±9.67
  8                 100.02^a^±5.02   137.49^b^±6.56   119.45^ab^±6.06   120.49^b^±6.05    119.36±7.66
  9                 96.36^a^±5.01    150.47^c^±5.54   121.82^b^±5.86    124.88^b^±5.39    123.38±11.06
  10                98.37^a^±5.64    162.35^c^±5.90   129.32^b^±5.58    126.64^b^±5.66    129.17±13.09
  11                95.30^a^±4.95    160.18^c^±5.02   134.92^b^±4.54    126.45^b^±5.47    129.21±13.38
  12                99.02^a^±4.86    169.91^c^±5.47   138.64^b^±6.06    132.46^b^±6.94    135.01±14.53
  Mean              100.33^a^±2.45   133.62^c^±7.18   118.74^bc^±4.58   115.70^ab^±3.79   

Mean within the row bearing different superscript (a, b, c) are significantly different (p\<0.05).

###### 

Effect of vitamin E supplementation on ALT activity (U/L) in As fed goats

  Period (Months)   Treatments      Mean                                              
  ----------------- --------------- --------------- ---------------- ---------------- ------------
  0                 10.85±0.56      10.13±0.42      10.10±0.76       9.40±0.42        10.12±0.30
  1                 10.73^a^±0.23   15.54^b^±0.52   12.04^ab^±0.98   11.67^ab^±0.47   12.50±1.05
  2                 11.35^a^±0.69   16.67^b^±0.88   13.80^ab^±1.34   12.04^a^±0.51    13.47±1.19
  3                 11.65^a^±0.47   18.23^b^±0.97   14.78^ab^±1.88   13.42^a^±0.58    14.52±1.39
  4                 11.17^a^±0.65   18.55^b^±1.02   14.59^ab^±1.97   13.61^a^±1.00    14.48±1.53
  5                 12.33^a^±0.76   19.14^b^±1.33   15.26^ab^±0.74   14.57^a^±0.88    15.32±1.42
  6                 12.16^a^±0.59   21.24^b^±1.12   16.23^a^±1.32    13.63^a^±0.85    15.81±1.99
  7                 12.44^a^±0.39   21.50^b^±1.35   15.35^a^±0.87    15.57^a^±0.93    16.21±1.90
  8                 12.18^a^±0.40   22.50^c^±1.53   16.54^b^±1.47    16.16^ab^±0.74   16.85±2.13
  9                 11.31^a^±0.79   24.28^c^±1.57   20.39^bc^±1.99   19.89^b^±1.60    18.97±2.74
  10                11.33^a^±0.57   24.09^b^±1.63   21.26^b^±2.06    20.60^b^±1.93    19.32±2.77
  11                10.21^a^±0.63   27.42^d^±1.41   24.10^cd^±1.37   19.78^b^±1.56    20.38±3.73
  12                10.53^a^±0.48   29.60^d^±0.99   26.37^cd^±1.21   19.95^b^±1.43    21.61±4.20
  Mean              11.40^a^±0.20   20.68^c^±1.43   16.99^bc^±1.31   15.41^b^±1.01    

Mean within the row bearing different superscript (a, b, c, d) are significantly different (p\<0.05).

[^1]: Dairy Cattle Nutrition Division, National Dairy Research Institute, Karnal, Haryana-132001, India
